We have located links that may give you full text access.
Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
Pathology, Research and Practice 2016 October
Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC) are two common skin malignancies with different potentials for invasion and metastasis. The mechanism responsible for various growth patterns observed in SCC and BCC is still not fully understood. The aim of this study was to investigate the expression of matrix metalloproteinase-10 in non-melanoma skin cancers, including BCC and SCC of the head and neck. The study group consisted of 60 specimens, including 30 BCC and 30 cutaneous SCC of the head and neck. Sections of tumor biopsy samples were immunohistochemically examined for the expression of MMP-10. Data were analyzed by SPSS (V.21) using Mann-Whitney and Kruskal Wallis tests. We found higher immunohistochemical expression of MMP-10 in tumor epithelium and stroma of SCC as compared with BCC. However, this difference was significant only in tumor epithelium (P=0.000). Moreover, the level of MMP-10 expression in tumor epithelium of grades III and II of SCC was significantly greater compared to grade I tumors (P<0.05).Our results suggest that the level of the MMP-10 expression in tumor epithelium of cutaneous SCC and BCC may contribute to the different invasive patterns observed in these tumors. Also, the expression of MMP-10 is associated with tumor differentiation in cutaneous HNSCC.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app